Purdue Pharma Faces $5.5B Criminal Sentence for Deceiving Regulators and Boosting Opioid Sales

Source: International Business Times

Purdue Pharma was ordered by a federal judge Tuesday to pay $5. 5 billion after admitting it misled regulators and boosted sales of its pain drug OxyContin. The ruling marks a major step in holding the company accountable for its role in the US opioid epidemic.